Oscar Health (OSCR) Scheduled to Post Earnings on Thursday

Oscar Health (NYSE:OSCR) will be posting its quarterly earnings results before the market opens on Thursday, November 7th. Analysts expect Oscar Health to post earnings of ($0.20) per share for the quarter. Persons that are interested in participating in the company’s earnings conference call can do so using this link.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings results on Wednesday, August 7th. The company reported $0.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.16 by $0.04. Oscar Health had a return on equity of 1.86% and a net margin of 0.25%. The firm had revenue of $2.20 billion for the quarter, compared to analyst estimates of $2.13 billion. During the same period last year, the company earned ($0.07) EPS. The firm’s quarterly revenue was up 44.6% on a year-over-year basis. On average, analysts expect Oscar Health to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Oscar Health Trading Up 1.3 %

NYSE OSCR opened at $18.33 on Wednesday. The company has a market cap of $4.43 billion, a P/E ratio of -140.99, a P/E/G ratio of 34.96 and a beta of 1.67. Oscar Health has a 12 month low of $5.65 and a 12 month high of $23.79. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.91 and a quick ratio of 0.91. The company has a 50-day moving average of $18.74 and a 200-day moving average of $18.43.

Analysts Set New Price Targets

A number of equities analysts have weighed in on OSCR shares. UBS Group initiated coverage on shares of Oscar Health in a research note on Monday, October 7th. They set a “neutral” rating and a $23.00 price target on the stock. Piper Sandler reaffirmed an “overweight” rating and issued a $28.00 target price on shares of Oscar Health in a research report on Tuesday, September 10th. Three investment analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $24.00.

Insider Transactions at Oscar Health

In related news, CFO Richard Scott Blackley sold 68,978 shares of the stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total value of $1,240,914.22. Following the completion of the sale, the chief financial officer now directly owns 884,213 shares in the company, valued at approximately $15,906,991.87. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, CFO Richard Scott Blackley sold 68,978 shares of the business’s stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $1,240,914.22. Following the transaction, the chief financial officer now directly owns 884,213 shares of the company’s stock, valued at approximately $15,906,991.87. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, EVP Alessandrea C. Quane sold 16,793 shares of the stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $17.06, for a total transaction of $286,488.58. Following the completion of the sale, the executive vice president now directly owns 392,607 shares of the company’s stock, valued at $6,697,875.42. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 169,569 shares of company stock valued at $3,007,069 over the last 90 days. Corporate insiders own 25.11% of the company’s stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.